Justia Regulation Tracker

---

[Federal Register: April 24, 2009 (Volume 74, Number 78)]
[Notices]               
[Page 18697-18698]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr24ap09-40]                         

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary

 
Defense Health Board (DHB) Meeting

AGENCY: Department of Defense.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the Federal Advisory Committee Act of 1972 (5 
U.S.C., Appendix as amended), the Sunshine in the Government Act of 
1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.150, and in 
accordance with section 10(a)(2) of Public Law, the following meeting 
of the Defense Health Board (DHB) is announced:

DATES: May 7-8, 2009.
    May 7, 2009.
    7 a.m.-12 p.m. (Open Session).
    12 p.m.-2:15 p.m. (Administrative Working Meeting).
    2:15 p.m.-5:15 p.m. (Open Session).
    May 8, 2009.
    8 a.m.-2 p.m. (Closed Session).

ADDRESSES: May 7, 2009, Ballroom, Sheraton Chrystal City Hotel, 1800 
Jefferson Davis Highway Arlington, VA 22202.
    May 8, 2009 Industrial College of the Armed Forces, Fort McNair, 
Washington, DC.

FOR FURTHER INFORMATION CONTACT: Commander Edmond F. Feeks, Executive 
Secretary, Defense Health Board, Five Skyline Place, 5111 Leesburg 
Pike, Suite 810, Falls Church, Virginia 22041-3206, (703) 681-8448, 
EXT. 1228, Fax: (703)-681-3317, edmond.feeks@tma.osd.mil. Additional 
information, agenda updates, and meeting registration are available 
online at the Defense Health Board Web site, http://www.ha.osd.mil/dhb. 
The public is encouraged to register for the meeting. If special 
accommodations are required to attend (sign language, wheelchair 
accessibility) please contact Ms. Lisa Jarrett at (703) 681-8448 ext. 
1280 by April 30, 2009. Written statements may be mailed to the above 
address, emailed to dhb@ha.osd.mil or faxed to (703) 681-3317.

SUPPLEMENTARY INFORMATION: 
    Purpose of the Meeting: The purpose of the meeting is to address 
and deliberate pending and new Board issues and provide briefings for 
Board members on topics related to ongoing Board business.
    Agenda: On May 7, 2009, the Board will receive a briefing on Iraqi 
Health

[[Page 18698]]

Sector Reconstruction. The following Defense Health Board Subcommittees 
will present updates to the Board: the Millennium Cohort Study, the 
Psychological Health External Advisory Subcommittee, the Trauma and 
Injury Subcommittee, the Vaccine Safety and Effectiveness Report, the 
National Capital Region Base Realignment and Closure Subcommittee, and 
the Traumatic Brain Injury External Advisory Subcommittee. The Board 
will also receive an informational briefing on the use of the Warren 
Cohort Serum Repository.
    Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR102-3.155, in the 
interest of national security, the Department of Defense has determined 
that the meeting on May 8, 2009 will be closed to the public. The Under 
Secretary of Defense (Personnel and Readiness), in consultation with 
the Office of the DoD General Counsel, has determined in writing that 
the public interest requires that the session on May 8, 2009 be closed 
to public because they will concern matters listed in section 
552b(c)(1) of title 5, United States Code. Specifically the information 
presented meets criteria established by an executive order to be kept 
secret in the interest of national defense and foreign policy.
    Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102-3.140 through 
102-3.165 and subject availability of space, the Defense Health Board 
meeting from 7 a.m. to 12 p.m. and from 2:15 p.m. to 5:15 p.m. on May 
7, 2009 is open to the public. Any member of the public wishing to 
provide input to the Defense Health Board should submit a written 
statement in accordance with 41 CFR 102-3.140(C) and section 10(a)(3) 
of the Federal Advisory Committee Act, and the procedures described in 
this notice. Written statement should be not longer than two type-
written pages and must address the following detail: The issue, 
discussion, and a recommended course of action. Supporting 
documentation may also be included as needed to establish the 
appropriate historical context and to provide any necessary background 
information.
    Individuals desiring to submit a written statement may do so 
through the Board's Designated Federal Officer at the address detailed 
above at any point. However, if the written statement is not received 
at least 10 calendar days prior to the meeting, which is subject to 
this notice, then it may not be provided to or considered by the 
Defense Health Board until the next open meeting.
    The Designated Federal Officer will review all timely submissions 
with the Defense Health Board Chairperson, and ensure they are provided 
to members of the Defense Health Board before the meeting that is 
subject to this notice. After reviewing the written comments, the 
Chairperson and the Designated Federal Officer may choose to invite the 
submitter of the comments to orally present their issue during an open 
portion of this meeting or at a future meeting.
    The Designated Federal Officer, in consultation with the Defense 
Health Board Chairperson, may, if desired, allot a specific amount of 
time for members of the public to present their issues for review and 
discussion by the Defense Health Board.

    Dated: April 20, 2009.
Morgan E. Frazier,
Alternate OSD Federal Register, Liaison Officer, Department of Defense.
[FR Doc. E9-9390 Filed 4-23-09; 8:45 am]

BILLING CODE 5001-06-P